Definitive HealthcareDH +4.43%51 5-Year Yield-on-Cost % is 0.00 as of Jul. 07, 2026. GuruFocus rates DH with a GF Score™ of 51/100 and a GF Value™ of $4.44 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 282 Healthcare Providers & Services companies, Definitive Healthcare ranks worse than 354609.57% on this metric.
Definitive Healthcare's yield on cost for the quarter that ended in Mar. 2026 was 0.00.
The historical rank and industry rank for Definitive Healthcare's 5-Year Yield-on-Cost % or its related term are showing as below:
DH's 5-Year Yield-on-Cost % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.925 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Definitive Healthcare 5-Year Yield-on-Cost % Related Terms
DH vs DRIO, CCLD, OPRX: 5-Year Yield-on-Cost % Comparison
For the Health Information Services subindustry, Definitive Healthcare's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Definitive Healthcare 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Definitive Healthcare's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Definitive Healthcare's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Definitive Healthcare (DH) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 07, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Definitive Healthcare and its competitors. According to the industry distribution chart, Definitive Healthcare ranks #999999 out of 282 companies in the Healthcare Providers & Services industry.
Is Definitive Healthcare's 5-Year Yield-on-Cost % too high?
Definitive Healthcare's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, Definitive Healthcare ranks #999999 out of 282 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Definitive Healthcare has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Definitive Healthcare's 5-Year Yield-on-Cost % compare to DRIO and CCLD?
According to the Healthcare Providers & Services industry distribution chart, Definitive Healthcare ranks #999999 out of 282 companies for 5-Year Yield-on-Cost %. This places Definitive Healthcare in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.93. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.93, based on 282 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Definitive Healthcare and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Definitive Healthcare's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Definitive Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Definitive Healthcare (DH) is currently considered Possible Value Trap. The stock's GF Value™ is $4.44, compared to a current price of $0.90 — trading 79.7% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Definitive Healthcare's overall GF Score™ is 51/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Definitive Healthcare (DH), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Definitive Healthcare (DH) Overvalued in 2026?
Based on GuruFocus' analysis, Definitive Healthcare stock appears to be undervalued.
The current stock price of $0.90 is trading 79.7% below its estimated GF Value™ of $4.44.
GuruFocus considers Definitive Healthcare to be Possible Value Trap.
Key valuation signals for DH:
5-Year Yield-on-Cost %: 0.00
GF Value™: $4.44 vs. price of $0.90 (79.7% below fair value)
No single metric tells the full story. See the DH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.
51GF Score
Get the complete analysis for DH
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DH has been successfully added to your 